Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Evaluate immunogenicity, reactogenicity, safety of GSK Biologicals’ MenC-TT vaccine (2 formulations) given with Infanrix hexa® + GSK Biologicals’ Hib MenC-TT vaccine (2 formulations) given with Infanrix penta® to infants in mths 3,4,5 of life
Meningococcal Vaccine
711202/001
NCT00135486
Infections, Meningococcal
Phase 2
 
A persistence study 711202/008 was conducted. An annotated case report form is not available for this study. A blank case report form will be provided.
June 2015

Powered by ideaPoint, Inc.